Radiological Simultaneous Portohepatic Vein Embolization (RASPE) Before Major Hepatectomy
Top Cited Papers
- 19 May 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 272 (2), 199-205
- https://doi.org/10.1097/sla.0000000000003905
Abstract
Objective: The aim of this retrospective study was to compare portal vein embolization (PVE) and radiologica simultaneous portohepatic vein embolization (RASPE) for future liver remnant (FLR) growth in terms of feasibility, safety, and efficacy. Summary of Background Data: After portal vein embolization (PVE), 15% of patients remain ineligible for hepatic resection due to insufficient hypertrophy of the FLR. RASPE has been proposed to induce FLR growth. Materials and Methods: Between 2016 and 2018, 73 patients were included in the study. RASPE was proposed for patients with a ratio of FLR to total liver volume (FLR/TLV) of <25% (RASPE group). This group was compared to patients who underwent PVE for a FLR/TLV <30% (PVE group). Patients in the 2 groups were matched for age, sex, type of tumor, and number of chemotherapy treatments. FLR was assessed by computed tomography before and 4 weeks after the procedure. Results: The technical success rate in both groups was 100%. Morbidity post-embolization, and the time between embolization and surgery were similar between the groups. In the PVE group, the FLR/TLV ratio before embolization was 31.03% (range: 18.33%-38.95%) versus 22.91% (range: 16.55-32.15) in the RASPE group (P< 0.0001). Four weeks after the procedure, the liver volume increased by 28.98% (range: 9.31%-61.23%) in the PVE group and by 61.18% (range: 23.18%-201.56%) in the RASPE group (P< 0.0001). Seven patients in the PVE group, but none in the RASPE group, had postoperative liver failure (P= 0.012). Conclusions: RASPE can be considered as "radiological associating liver partition and portal vein ligation for staged hepatectomy." RASPE induced safe and profound growth of the FLR and was more efficient than PVE. RASPE also allowed for extended hepatectomy with less risk of post-operative liver failure.Keywords
This publication has 41 references indexed in Scilit:
- Portal Vein Embolization before Right Hepatectomy: Improved Results Using n-Butyl-Cyanoacrylate Compared to Microparticles Plus CoilsCardioVascular and Interventional Radiology, 2013
- Portal Vein Embolization Before Liver Resection: A Systematic ReviewCardioVascular and Interventional Radiology, 2012
- Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)Surgery, 2011
- Sequential Preoperative Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization to Induce Further Liver Regeneration in Patients With Hepatobiliary MalignancyAnnals of Surgery, 2009
- Hepatic Resection for Noncolorectal Nonendocrine Liver MetastasesTransactions of the ... Meeting of the American Surgical Association, 2006
- Management of hepatocellular carcinomaJournal of Hepatology, 2005
- The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resectionGut, 2005
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Aging Reduces Proliferative Capacities of Liver by Switching Pathways of C/EBPα Growth ArrestCell, 2003
- Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured LiverAnnals of Surgery, 2000